Advisor Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Advisor Partners's DGX Position: Q2 2022 in Review
Advisor Partners increased its Quest Diagnostics (DGX) stake by 5.9% in Q2 2022, buying an estimated $36.8K and bringing the position to 4,808 shares worth $639K. The position accounts for 0.05% of the portfolio, ranked #406.
Advisor Partners first reported a position in DGX in Q4 2016 and has held it in 23 quarters since. The position peaked at $1.06M in Q4 2019. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Advisor Partners held 4,808 shares of Quest Diagnostics worth $639K as of Q2 2022.
- Advisor Partners bought 270 Quest Diagnostics shares in Q2 2022, an estimated $36.8K.
- Quest Diagnostics made up 0.05% of Advisor Partners's portfolio in Q2 2022, its #406 holding.
- Advisor Partners first reported a position in Quest Diagnostics in Q4 2016 and has held it in 23 quarters since.
- Advisor Partners's Quest Diagnostics position peaked at $1.06M in Q4 2019.
- 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.